Selective class III antiarrhythmic agents. 1 Bis(arylalkyl)amines.

Area of Science:

• Pharmacology
• Cardiovascular Science
• Medicinal Chemistry

Background:

• Cardiac arrhythmias pose a significant health burden.
• Existing antiarrhythmic drugs have limitations, necessitating novel therapeutic agents.
• Selective Class III antiarrhythmic agents offer a promising approach by targeting the cardiac action potential duration.

Purpose of the Study:

• To synthesize and evaluate a series of bis(arylalkyl)amines for antiarrhythmic properties.
• To identify structural features that enhance selective prolongation of the effective refractory period.
• To characterize the mechanism of action of the most promising compound.

Main Methods:

• Synthesis of novel bis(arylalkyl)amine compounds.
• Electrophysiological studies on isolated cardiac tissue to assess effects on action potential and refractory period.
• Pharmacological characterization of compound 16, including its interaction with cardiac potassium channels.

Main Results:

• Several bis(arylalkyl)amines demonstrated the ability to prolong the cardiac action potential.
• Compounds with methanesulfonamido moieties on both aryl rings showed advantageous properties.
• Compound 16 exhibited potent and selective Class III antiarrhythmic activity by blocking cardiac potassium channels.

Conclusions:

• Bis(arylalkyl)amines represent a promising class of selective Class III antiarrhythmic agents.
• The presence of dual methanesulfonamido groups is a key structural feature for efficacy.
• Compound 16 is a potent and selective antiarrhythmic drug candidate with a defined mechanism of action via potassium channel blockade.